These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7680910)

  • 1. Effect of galanin on plasma levels of oxytocin and cholecystokinin.
    Björkstrand E; Hulting AL; Meister B; Uvnäs-Moberg K
    Neuroreport; 1993 Jan; 4(1):10-2. PubMed ID: 7680910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxytocin modulates the effects of galanin in carrageenan-induced hyperalgesia in rats.
    Lundeberg T; Meister B; Björkstrand E; Uvnäs-Moberg K
    Brain Res; 1993 Apr; 608(2):181-5. PubMed ID: 7684311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma concentrations of cholecystokinin octapeptide and food intake in male rats treated with cholecystokinin octapeptide.
    Lindén A; Uvnäs-Moberg K; Forsberg G; Bednar I; Södersten P
    J Endocrinol; 1989 Apr; 121(1):59-65. PubMed ID: 2565947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between the concentration of cholecystokinin-like immunoreactivity in plasma and food intake in male rats.
    Lindén A; Södersten P
    Physiol Behav; 1990 Dec; 48(6):859-63. PubMed ID: 2087518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of cholecystokinin in feeding and lactation.
    Lindén A
    Acta Physiol Scand Suppl; 1989; 585():i-vii, 1-49. PubMed ID: 2603747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galanin stimulates the release of cholecystokinin from nerve fibres in the pituitary neurointermediate lobe.
    Meister B; Hulting AL; Uvnäs-Moberg K; Hökfelt T
    Neuroreport; 1993 Jun; 4(6):631-4. PubMed ID: 7688586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term changes in gastrin, cholecystokinin and insulin in response to oxytocin treatment.
    Petersson M; Hulting A; Andersson R; Uvnäs-Moberg K
    Neuroendocrinology; 1999 Mar; 69(3):202-8. PubMed ID: 10087452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of cholecystokinin receptor in the inhibition of gastrointestinal motility by oxytocin in ovariectomized rats.
    Wu CL; Doong ML; Wang PS
    Eur J Pharmacol; 2008 Feb; 580(3):407-15. PubMed ID: 18078924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of oxytocin neurones by systemic cholecystokinin is unchanged by morphine dependence or withdrawal excitation in the rat.
    Brown CH; Munro G; Murphy NP; Leng G; Russell JA
    J Physiol; 1996 Nov; 496 ( Pt 3)(Pt 3):787-94. PubMed ID: 8930844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracerebroventricularly administered corticotropin-releasing factor releases somatostatin through a cholinergic, vagal pathway in freely fed rats.
    Smedh U; Uvnäs-Moberg K
    Acta Physiol Scand; 1994 Jun; 151(2):241-8. PubMed ID: 7942060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of amylin on feeding of goldfish: interactions with CCK.
    Thavanathan R; Volkoff H
    Regul Pept; 2006 Jan; 133(1-3):90-6. PubMed ID: 16239037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrical activation and c-fos mRNA expression in rat neurosecretory neurones after systemic administration of cholecystokinin.
    Hamamura M; Leng G; Emson PC; Kiyama H
    J Physiol; 1991 Dec; 444():51-63. PubMed ID: 1822561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of gastrointestinal peptides on pancreatic secretion in response to different stimulants in conscious rats.
    Ami M; Doi R; Inoue K; Chowdhury P; Rayford PL
    Int J Pancreatol; 1993 Dec; 14(3):245-52. PubMed ID: 8113626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxytocin and cholecystokinin secretion in women with colectomy.
    Ohlsson B; Rehfeld JF; Forsling ML
    BMC Gastroenterol; 2004 Oct; 4():25. PubMed ID: 15471545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholecystokinin octapeptide analogues suppress food intake via central CCK-A receptors in mice.
    Hirosue Y; Inui A; Teranishi A; Miura M; Nakajima M; Okita M; Nakajima Y; Himori N; Baba S; Kasuga M
    Am J Physiol; 1993 Sep; 265(3 Pt 2):R481-6. PubMed ID: 8214137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurohypophyseal secretion in response to cholecystokinin but not meal-induced gastric distention in humans.
    Miaskiewicz SL; Stricker EM; Verbalis JG
    J Clin Endocrinol Metab; 1989 Apr; 68(4):837-43. PubMed ID: 2921313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Centrally administered cholecystokinin suppresses feeding through a peripheral-type receptor mechanism.
    Crawley JN; Fiske SM; Durieux C; Derrien M; Roques BP
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1076-80. PubMed ID: 2046021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of peripherally administered cholecystokinin-8 and secretin on feeding/drinking and oxytocin-mRFP1 fluorescence in transgenic rats.
    Motojima Y; Kawasaki M; Matsuura T; Saito R; Yoshimura M; Hashimoto H; Ueno H; Maruyama T; Suzuki H; Ohnishi H; Sakai A; Ueta Y
    Neurosci Res; 2016 Aug; 109():63-9. PubMed ID: 26919961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Centrally administered galanin modifies vasopressin and oxytocin release from the hypothalamo-neurohypophysial system of euhydrated and dehydrated rats.
    Ciosek J; Cisowska A
    J Physiol Pharmacol; 2003 Dec; 54(4):625-41. PubMed ID: 14726616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intraperitoneal and intravenous administration of cholecystokinin-8 and apolipoprotein AIV on intestinal lymphatic CCK-8 and apo AIV concentration.
    Lo CM; Xu M; Yang Q; Zheng S; Carey KM; Tubb MR; Davidson WS; Liu M; Woods SC; Tso P
    Am J Physiol Regul Integr Comp Physiol; 2009 Jan; 296(1):R43-50. PubMed ID: 19020287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.